|
IDS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.60569948635259E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.76999584065175E-11 |
| Normal-vs-Stage2 |
7.91800000000675E-05 |
| Normal-vs-Stage3 |
2.44349999999338E-05 |
| Normal-vs-Stage4 |
1.237070E-03 |
| Stage1-vs-Stage2 |
6.872000E-01 |
| Stage1-vs-Stage3 |
1.790380E-01 |
| Stage1-vs-Stage4 |
2.053900E-02 |
| Stage2-vs-Stage3 |
5.968200E-01 |
| Stage2-vs-Stage4 |
1.759000E-01 |
| Stage3-vs-Stage4 |
3.588400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.15390047411768E-10 |
| Normal-vs-AfricanAmerican |
2.516000E-02 |
| Normal-vs-Asian |
1.031900E-02 |
| Caucasian-vs-AfricanAmerican |
3.620300E-02 |
| Caucasian-vs-Asian |
8.056600E-01 |
| AfricanAmerican-vs-Asian |
3.114000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93819968355535E-10 |
| Normal-vs-Female |
1.16539999994725E-06 |
| Male-vs-Female |
1.302760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.496140E-02 |
| Normal-vs-Age(41-60Yrs) |
7.82759967954405E-10 |
| Normal-vs-Age(61-80Yrs) |
3.52060000041732E-08 |
| Normal-vs-Age(81-100Yrs) |
1.027590E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.124600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.021800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.355600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.261400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.623000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.783000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.364800E-04 |
| Normal-vs-Grade 2 |
4.83335593770562E-12 |
| Normal-vs-Grade 3 |
3.28620000000779E-06 |
| Normal-vs-Grade 4 |
1.085720E-02 |
| Grade 1-vs-Grade 2 |
9.702600E-01 |
| Grade 1-vs-Grade 3 |
2.484400E-01 |
| Grade 1-vs-Grade 4 |
1.382980E-01 |
| Grade 2-vs-Grade 3 |
1.817360E-03 |
| Grade 2-vs-Grade 4 |
1.479660E-03 |
| Grade 3-vs-Grade 4 |
3.208200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.71813690946965E-12 |
| Normal-vs-ccB subtype |
3.53699999955381E-07 |
| ccA subtype-vs-ccB subtype |
7.377800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.30570000262043E-08 |
| Normal-vs-N1 |
2.354400E-01 |
| N0-vs-N1 |
6.806600E-01 |
|
|
